Similar Papers

Paper Title
Journal
Date
Author
The Potential of PD-1 and PD-L1 as Prognostic and Predictive Biomarkers in Colorectal Adenocarcinoma Based on TILs Grading.
Nur Rahmah Rasyid ... Muhammad Husni Cangara
Current oncology (Toronto, Ont.) | VOL. 31
Nur Rahmah Rasyid, et. al.Nur Rahmah Rasyid ... Muhammad Husni Cangara
25 Nov 2024
Prognostic significance of programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expression in uterine carcinosarcoma
Umran Kucukgoz Gulec ... Mehmet Ali Vardar
European Journal of Obstetrics & Gynecology and Reproductive Biology | VOL. 244
Umran Kucukgoz Gulec, et. al.Umran Kucukgoz Gulec ... Mehmet Ali Vardar
08 Nov 2019
The Prognostic Impact of PD-L1 and CD8 Expression in Anal Cancer Patients Treated with Chemoradiotherapy
W.N Jiang ... C.M Doll
International Journal of Radiation Oncology*Biology*Physics | VOL. 102
W.N Jiang, et. al.W.N Jiang ... C.M Doll
20 Oct 2018
Evaluating the PD-1 Axis and Immune Effector Cell Infiltration in Oropharyngeal Squamous Cell Carcinoma
Jonathan D Schoenfeld ... Danielle N Margalit
International Journal of Radiation Oncology*Biology*Physics | VOL. 102
Jonathan D Schoenfeld, et. al.Jonathan D Schoenfeld ... Danielle N Margalit
29 Jun 2018
View more papers

More From: Journal for ImmunoTherapy of Cancer

Paper Title
Journal
Date
Author
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry
Alessio Cortellini ... Biagio Ricciuti
Journal for ImmunoTherapy of Cancer | VOL. 13
Alessio Cortellini, et. al.Alessio Cortellini ... Biagio Ricciuti
04 Feb 2025
Modulating lipid metabolism improves tumor immunotherapy
Yu Ping ... Yi Zhang
Journal for ImmunoTherapy of Cancer | VOL. 13
Yu Ping, et. al.Yu Ping ... Yi Zhang
04 Feb 2025
Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): safety, efficacy, and exploratory biomarker analysis
Cameron Wood ... Neal Ready
Journal for ImmunoTherapy of Cancer | VOL. 13
Cameron Wood, et. al.Cameron Wood ... Neal Ready
04 Feb 2025
Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma
Thomas Eigentler ... Ulrike Gnad-Vogt
Journal for ImmunoTherapy of Cancer | VOL. 13
Thomas Eigentler, et. al.Thomas Eigentler ... Ulrike Gnad-Vogt
04 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.